Skip to Main Content (Press Enter)

Logo UNIME
  • ×
  • Home
  • Degrees
  • Courses
  • Jobs
  • People
  • Outputs
  • Organizations
  • Third Mission
  • Expertise & Skills

Expertise & Skills
Logo UNIME

|

UNIFIND - Expertise & Skills

unime.it
  • ×
  • Home
  • Degrees
  • Courses
  • Jobs
  • People
  • Outputs
  • Organizations
  • Third Mission
  • Expertise & Skills
  1. Outputs

The abrogation of phosphorylation plays a relevant role in the CCR5 signalosome formation with natural antibodies to CCR5

Academic Article
Publication Date:
2018
abstract:
The exposure to CCR5 (CC chemokine receptor 5) specific natural antibodies in vitro produces a Class B β-arrestin2-dependent CCR5 retention with the aid of ERK1, due to the formation of a CCR5 signalosome, which remains stable for at least 48 h. Considering that β-arrestins and MAPKs are receptive to environmental signals, their signal complexes could be one of the key junction for GPCRs internalization related signal transduction. Here, we demonstrate that, in T cells, the phosphorylation status of either CCR5 receptor or ERK1 protein is necessary to drive the internalized receptor into the early endosomes, forming the CCR5 signalosome. In particular, our data show that β-arrestin2/ERK1 complex is a relevant transducer in the CCR5 signaling pathway. Understanding the mechanism of CCR5 regulation is essential for many inflammatory disorders, tumorigenesis and viral infection such as HIV
Iris type:
14.a.1 Articolo su rivista
Keywords:
CCR5; CCR5 based therapy; CCR5 signalosome; ESN; HIV infection; HIV protection; LTNP; anti CCR5 antibodies
List of contributors:
Venuti, A; Pastori, C; Siracusano, G; Pennisi, R; Riva, A; Tommasino, M; Sciortino, Mt; Lopalco, L.
Authors of the University:
PENNISI Rosamaria
SCIORTINO Maria Teresa
Handle:
https://iris.unime.it/handle/11570/3119173
Published in:
VIRUSES
Journal
  • Overview

Overview

URL

https://www.ncbi.nlm.nih.gov/pubmed/29283386
  • Guide
  • Help
  • Accessibility
  • Privacy
  • Use of cookies
  • Legal notes

Powered by VIVO | Designed by Cineca | 26.5.0.0